Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for Nitrendipine (compound)


PubChem
Name: Nitrendipine
PubChem Compound ID: 10893799
Description: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
Molecular formula: C18H20N2O6
Molecular weight: 362.369 g/mol
DrugBank
Identification
Name: Nitrendipine
Name (isomeric): DB01054
Drug Type: small molecule
Description: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
Synonyms:
Nitrendipinum [INN-Latin]; Nitrendipino [INN-Spanish]; Nitrendipin
Brand: Nidrel, Baypress, Nitrepin, Bylotensin, Bayotensin, Deiten
Category: Vasodilator Agents, Calcium Channel Blockers, Antihypertensive Agents
CAS number: 39562-70-4
Pharmacology
Indication: For the treatment of mild to moderate hypertension
Pharmacology:
Nitrendipine, a dihydropyridine calcium-channel blocker, is used alone or with an angiotensin-converting enzyme inhibitor, to treat hypertension, chronic stable angina pectoris, and Prinzmetal's variant angina. Nitrendipine is similar to other peripheral vasodilators. Nitrendipine inhibits the influx of extra cellular calcium across the myocardial ...
show more »
Mechanism of Action:
By deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum, Nitrendipine inhibits the influx of extracellular calcium across the myocardial and vascular smooth muscle cell membranes The decrease in intracellular calcium inhibits the contractile processes of the ...
show more »
Protein binding: > 99%
Affected organisms: Humans and other mammals
Interactions
Drug interaction:
CimetidineCimetidine increases the effect of the calcium channel blocker, nitrendipine.
TipranavirTipranavir may decrease the metabolism and clearance of the calcium channel blocker, Nitrendipine. Monitor for changes in Nitrendipine therapeutic and adverse effects if Tipranavir is initiated, discontinued or dose changed.
TelithromycinTelithromycin may reduce clearance of Nitrendipine. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Nitrendipine if Telithromycin is initiated, discontinued or dose changed.
VoriconazoleVoriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of nitrendipine by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of nitrendipine if voriconazole is initiated, discontinued or dose changed.
ThiopentalThe CYP3A4 inducer, Thiopental, may increase the metabolism and clearance of Nitrendipine, a CYP3A4 substrate. Monitor for changes in the therapeutic/adverse effects of Nitrendipine if Thiopental is initiated, discontinued or dose changed.
show more »

Targets


Enzymes


Transporters